Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)

Creative Commons License

Sebastian S., Hernandez V., Myrelid P., Kariv R., Tsianos E., TÖRÜNER M., ...Daha Fazla

JOURNAL OF CROHNS & COLITIS, cilt.8, sa.1, ss.5-18, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 8 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1016/j.crohns.2013.04.008
  • Dergi Adı: JOURNAL OF CROHNS & COLITIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.5-18
  • Anahtar Kelimeler: Colorectal cancer, Epidemiology, Chemoprevention, Pathogenesis, Outcomes, PRIMARY SCLEROSING CHOLANGITIS, DOSE URSODEOXYCHOLIC ACID, CHRONIC INTESTINAL INFLAMMATION, COLITIS-ASSOCIATED DYSPLASIA, NF-KAPPA-B, ULCERATIVE-COLITIS, CROHNS-DISEASE, INCREASED RISK, MICROSATELLITE INSTABILITY, 5-AMINOSALICYLIC ACID
  • Ankara Üniversitesi Adresli: Evet

Özet

Epidemiological studies demonstrate an increased risk of colorectal cancer in patients with inflammatory bowel disease (IBD). A detailed literature review was conducted on epidemiology, risk factors, pathophysiology, chemoprevention and outcomes of colorectal cancer (CRC) in IBD as part of the 3rd ECCO scientific pathogenesis workshop. Crown Copyright (C) 2013 Published by Elsevier B.V. on behalf of European Crohn's and Colitis Organisation. All rights reserved.